ABBOTT LABORATORIES (ABT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for ABBOTT LABORATORIES (ABT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 49/100 — a percentile rank of ABBOTT LABORATORIES’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $167.3B |
| P / E | 30.8× |
| P / S | 3.6× |
| EV / EBITDA | 18.1× |
| Gross margin | 56.6% |
| Operating margin | 15.8% |
| Net margin | 11.6% |
| Return on equity | 10.6% |
| ROIC | 6.7% |
| Revenue growth | 8.1% |
| Debt / equity | 0.6× |
| Dividend yield | 2.5% |
Is ABBOTT LABORATORIES overvalued? P/E looks fair vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks undervalued vs its 5-year range.
Independent of the events above — derived from ABBOTT LABORATORIES’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact